Share the Tech If mRNA vaccine technology from Moderna, BioNTech and Pfizer were shared, manufacturers in low- and middle-income countries could produce vaccines for global pandemic preparedness, as well as diseases of concern such as HIV, TB and malaria.
MSF Access Campaign If @GileadSciences’ patent is revoked in Europe, as it has been in certain countries, it would represent a major step toward enabling production and importation of affordable generic versions of #sofosbuvir. #BadPatentsCostLives #hepC 07:25 - 11 Sep 2018